Nifedipina Sandoz (Nifedipine)

Nifedipine, the active ingredient in Nifedipina Sandoz, is a calcium channel blocker presented as an oral formulation for oral use. It is employed to lower high blood pressure, relieve chest pain from angina, and improve blood flow in Raynaud's phenomenon. By relaxing vascular smooth muscle, it reduces peripheral resistance and myocardial oxygen demand.

GNH USA supplies Nifedipina Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and ensuring product quality through stringent quality‑assurance processes.

Nifedipine is used in cardiovascular conditions that involve abnormal vascular tone or myocardial oxygen demand.

- Hypertension: lowers systolic and diastolic blood pressure, helping to control high blood pressure. - Angina pectoris: relieves chest pain by decreasing cardiac workload and oxygen consumption. - Raynaud's phenomenon: improves peripheral blood flow, reducing the frequency and severity of vasospastic attacks.

Nifedipine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warmth and redness, typically on the face or neck. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: sensation of light‑headedness, especially on standing.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that can cause fainting. - Myocardial infarction: rare occurrence of heart attack, particularly in patients with existing coronary disease. - Severe allergic reaction: includes rash, swelling, or difficulty breathing.

Before initiating therapy, several safety considerations should be reviewed.

- Monitor blood pressure: regularly check to avoid excessive hypotension. - Assess cardiac function: evaluate for ischemic heart disease or recent myocardial infarction. - Review concomitant medications: consider potential interactions, especially with CYP3A4 inhibitors. - Use caution in hepatic impairment: dose adjustments may be required. - Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension. - Store at room temperature: keep in the original pack, protect from moisture.

Nifedipine can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase nifedipine levels. - Grapefruit juice: can raise plasma concentrations, heightening adverse effects. - Beta‑blockers: combined use may cause excessive bradycardia. - Digoxin: levels may rise, increasing risk of toxicity. - Simvastatin: risk of myopathy is amplified.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance hypotensive effect. - NSAIDs: can attenuate antihypertensive response.